Gsm Foils Ltd · NSE:GSMFOILS

Gsm Foils — Q3 FY26 Earnings Presentation

30 slides from Gsm Foils's earnings presentation, Jan 30, 2026

  1. Slide 1: GSM Foils Limited – Investor Presentation Q3/9M FY26 filing letter

    GSM FOILS LIMITED CIN: U43303MH2023PLC405459 REGISTERED OFFICE: GALA NO 06/106/206/306, SAPPHIRE BUILDING, DIAMOND INDUSTRIAL ESTATE, VASAI (E), PALGHAR - 401208, MAHARASHTRA PHONE NO.: +91 91 84689 68102 EMAIL ID: info@gsmfoils.com WEBSITE: www.gsmfoils.com January 30, 2026 To, National Stock Excha

  2. Slide 2: GSM Foils Ltd Investor Presentation – January 2026

    GSM Foils Ltd Investor Presentation – January 2026 Investor Presentation – FY25 1

  3. Slide 3: Company Overview

    Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance

  4. Slide 4: GSM Foils At A Glance

    GSM Foils At A Glance • Established in 2019, GSM Foils specializes in the manufacturing of a wide range of Blister Foils and Aluminium Pharma Foils for the pharmaceutical industry. • We source raw materials from reputed, industry-recognized vendors, ensuring consistency and reliability in product qu

  5. Slide 5: Company Snapshot

    Company Snapshot 2019 14+ ~25000 Sq. Ft 15,000+ Presence in States Manufacturing Area MT/Annum Year of Establishment Production Capacity ISO 20 – 40 176.5 Cr 13.6 Cr 9001:2015 Microns 9M-FY26 Revenue 9M-FY26 PAT Certification Product Range 16+ 90+ 50+ In-House Advance Units Client Base Employees QA

  6. Slide 6: Our Journey

    Our Journey Formed company Touched almost Achieved the Converted LLP firm to milestone of crossing in the name of 80 % of our public limited and 100 Cr+ Annual GSM FOILS LLP capacity during shifted to new Turnover. and started peak covid and did premises for further Operationalized a aluminum foil a

  7. Slide 7: Product Portfolio

    Product Portfolio Blister Foil Aluminium Strip Pharma Foils Blister Pack Formation Superior Protection Consist of a thermoformed plastic tray or cold- Aluminium foils provide complete insulation formed tray sealed with aluminium foil or plastic against light, gases, moisture, and germs, ensuring lid

  8. Slide 8: Blister Foils

    Blister Foils Push-Through Blister Peel-Push Blister Packaging Packaging Medication is dispensed by peeling Medication is released by tearing open back the lidding and pushing through the package, constructed from paper, the aluminium foil; lidding is layered PET, and aluminium foil/HSC. with paper

  9. Slide 9: Aluminium Strip Pharma Foils

    Aluminium Strip Pharma Foils 30-micron Strip Foil 40-micron Strip Foil A thicker 40-micron aluminum foil A 30-micron aluminum foil with 150 with 150 GSM LDPE, providing GSM LDPE, designed for standard enhanced strength and barrier pharmaceutical packaging. properties. Used for packaging moisture-sen

  10. Slide 10: Comprehensive Quality Control Measures

    Comprehensive Quality Control Measures Bursting Strength Test GSM Calculator Measures the maximum pressure required to rupture the foil, ensuring Calculates the grammage per square meter, ensuring material consistency durability. and quality. Peeling Strength Test Digital Controlled Hot Plate Assess

  11. Slide 11: Well Equipped Manufacturing Facility – Vasai, Maharashtra

    Well Equipped Manufacturing Facility – Vasai, Maharashtra 1. Fully Equipped Multi-Storey Facility Our manufacturing unit, spread across 7,973 sq. ft. in Vasai, Mumbai, consists of three floors and a ground level. It is designed to support end-to-end operations including R&D, production, quality test

  12. Slide 12: New Manufacturing Facility – Ahmedabad, Gujarat

    New Manufacturing Facility – Ahmedabad, Gujarat Strategic Capacity Expansion to Support Growth 17,000 Sq Ft 10k+ MT 40-50% Approximate Annual Utilization target Leased Area Capacity by March 2026 • The Ahmedabad facility has been established to support the next phase of GSM Foils’ growth by expandin

  13. Slide 13: Delivering Value Through Quality, Customization, and Innovation

    Delivering Value Through Quality, Customization, and Innovation Quality Assurance Tailored Client Product Innovation Vertical Integration & Compliance Solutions Ensures top-quality products Offers customized packaging and Strong supplier partnerships Continuous investment in R&D through advanced tes

  14. Slide 14: Our Management Team

    Our Management Team Mohansingh L Parmar Sagar Girish Bhanushali Managing Director CFO, Whole Time Director 13 • Completed Primary Education under the • Holds a Bachelor’s Degree in Commerce from the Maharashtra State Board and FYJC from P.D. Lions University of Mumbai (2015). College of Commerce & E

  15. Slide 15: Certifications

    Certifications ISO CERTIFICATE RESIDUAL -SOLVENT DECLARATION TSE/BSE DECLARATION FOOD GRADE DECLARATION BIS CERTIFICATE CGMP CERTIFICATE 14 Investor Presentation - 9M FY26

  16. Slide 16: Industry Overview

    Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance

  17. Slide 17: India & the World: Expanding Opportunities in Pharma-Focused Foil Packaging

    India & the World: Expanding Opportunities in Pharma-Focused Foil Packaging India: A Growing Market for Aluminium Foils Global Aluminium Foil Market: Expanding Horizons • Global market size estimated at USD 30+ billion • India is one of the largest consumers of aluminium foils in Asia • Major Market

  18. Slide 18: Industry Tailwinds for Aluminium Foils in Pharma Applications

    Industry Tailwinds for Aluminium Foils in Pharma Applications Rising Growth in Generic Regulatory Push for Innovation in Drug Biosimilars & Pharmaceutical Drugs & OTC Market Tamper-Proof, Delivery – Rise in Biologics Boom Exports from India Barrier-Grade Blister Packaging Packaging • India exported

  19. Slide 19: Strategic Overview

    Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance

  20. Slide 20: Our Strategic Growth Roadmap

    Our Strategic Growth Roadmap 1 4 We aim to strengthen our footprint across We plan to expand into Lamitube manufacturing India by entering new and underpenetrated within the pharmaceutical packaging sector, regions. This strategic move is expected to enabling value addition, improved margin unlock f

  21. Slide 21: Our Core Strengths

    Our Core Strengths 4 Operational Excellence 2 1 To remain cost-competitive and improve profitability, we continuously work on optimizing internal processes. Our 24-hour manufacturing operation ensures productivity across three shifts. We also focus on process 3 4 improvements, better inventory contr

  22. Slide 22: Half-Yearly Financial Performance

    Company Overview Industry Overview Strategic Overview Half-Yearly Financial Performance Historical Financial Performance

  23. Slide 23: Q3/9M FY26 – Performance Highlights

    Q3/9M FY26 – Performance Highlights Revenue (INR Lacs) EBITDA (INR Lacs) and EBITDA Margin (%) PAT (INR Lacs) and PAT Margin (%) +84.14% +94.78% +96.01% 788.84 Q3 FY26 6,632.88 533.14 11.89% 3,602.15 405.00 8.04% 271.99 11.24% 7.55% Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 Revenue (INR Lacs)

  24. Slide 24: Nine-Monthly Income statement

    Nine-Monthly Income statement Particulars (In INR Lacs) Q3 FY26 Q3 FY25 Y-o-Y Q2 FY26 Q-o-Q 9M FY26 9M FY25 Y-o-Y Revenue from Operations 6,632.88 3,602.15 84.14% 5,813.59 14.09% 17,646.50 8,819.34 100.09% Cost of Materials consumed 5,795.30 3,045.24 5,369.92 15,865.26 7,712.95 Changes in Inventorie

  25. Slide 25: Historical Financial Performance

    Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance

  26. Slide 26: Historical Income statement

    Historical Income statement Particulars (In INR Lacs) FY24* FY25 9M FY26 Revenue from Operations 4,083.39 13,379.99 17,646.50 Cost of Materials consumed 3,557.25 11,585.95 15,865.26 Changes in Inventories of finished goods, work-in-progress and stock-in-trade -250.43 -398.44 -887.98 Gross Profit 776

  27. Slide 27: Historical Balance Sheet

    Historical Balance Sheet Equity & Liabilities(In INR Lacs) Mar-24 Mar-25 Sep-25 Assets(In INR Lacs) Mar-24 Mar-25 Sep-25 Shareholders' Fund Non ‐ Current Assets (a) Equity share capital 937.17 1,281.17 1,409.27 Property, plant and equipment (b) Other equity 166.09 1,843.08 4,825.67 (i)Tangible Asset

  28. Slide 28: Historical Cash Flow Statement

    Historical Cash Flow Statement Particulars (In INR Lacs) Mar-24 Mar-25 Sep-25 Cash Flow from Operating Activities Profit before Tax 185.25 1,362.82 1,111.95 Adjustment for Non-Operating Items 13.26 28.20 19.56 Operating Profit before Working Capital Changes 198.51 1,391.02 1,131.51 Changes in Workin

  29. Slide 29: Growth in Key Ratios

    Growth in Key Ratios Revenue (INR Lacs) EBITDA (INR Lacs) and EBITDA Margin (%) PAT (INR Lacs) and PAT Margin (%) 17,646.50 1,355.76 2,035.32 13,379.99 7.68% 965.10 1,520.51 11.53% 7.21% 4,083.39 11.36% 3.35% 6.61% 270.04 136.80 FY24 FY25 9M FY26 FY24 FY25 9M FY26 FY24 FY25 9M FY26 ROCE (%) ROE (%)

  30. Slide 30: Thank You

    GSM Foils Limited CIN: U43303MH2023PLC405459 Email ID: investors@gsmfoils.com Tel: +9184689 68102 Website: www.gsmfoils.com Thank You Investor Relations Partner X-B4 Advisory LLP Rasika Sawant / Aagam Shah Tel: +91 95944 57518 / +91 8850166932 Email ID: rasika@x-b4.com / aagam@x-b4.com Website: www.

GSM Foils — Q3 FY26 Earnings Presentation on 6ix